Lyell Immunopharma, Inc.
LYEL
$17.92
-$1.10-5.78%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.65% | 15.48% | -8.10% | -18.72% | -15.89% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 59.95% | 58.13% | -32.21% | -11.76% | -4.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -20.49% | 16.30% | -8.72% | -18.55% | -15.65% |
|
|
|||||
| Total Current Assets | -20.49% | 16.30% | -8.72% | -18.55% | -15.65% |
| Net Property, Plant & Equipment | -5.28% | -5.71% | -11.36% | -7.09% | -41.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 56.68% | 0.39% | -16.14% | -22.28% | 18.00% |
| Total Assets | -16.65% | 5.84% | -10.32% | -12.44% | -20.73% |
|
|
|||||
| Total Accounts Payable | 12.66% | -24.00% | -9.36% | -30.53% | 49.22% |
| Total Accrued Expenses | -28.55% | 50.39% | -15.01% | -21.92% | 34.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 3.30% | 3.31% | 11.77% |
| Total Finance Division Other Current Liabilities | -- | -- | -13.52% | -42.35% | 1,121.83% |
| Total Other Current Liabilities | -- | -- | -13.52% | -42.35% | 1,121.83% |
| Total Current Liabilities | 55.00% | -13.62% | -10.61% | -23.24% | 60.50% |
|
|
|||||
| Total Current Liabilities | 55.00% | -13.62% | -10.61% | -23.24% | 60.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.34% | -4.96% | -4.61% | -4.20% | -0.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -80.72% | -11.52% | -3.53% | -3.44% | -8.75% |
| Total Liabilities | 16.50% | -8.88% | -7.23% | -13.66% | 22.05% |
|
|
|||||
| Common Stock & APIC | 3.31% | 3.96% | 0.30% | 0.35% | 2.65% |
| Retained Earnings | -9.52% | -2.70% | -3.05% | -3.88% | -16.64% |
| Treasury Stock & Other | 20.40% | 252.63% | -63.92% | -45.70% | -61.71% |
| Total Common Equity | -24.59% | 10.10% | -11.17% | -12.10% | -27.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -24.59% | 10.10% | -11.17% | -12.10% | -27.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -24.59% | 10.10% | -11.17% | -12.10% | -27.86% |
|
|
|||||